Addus HomeCareADUS
About: Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
Employees: 34,846
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
225% more call options, than puts
Call options by funds: $2.99M | Put options by funds: $918K
100% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 2 (+1) [Q3]
63% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 35
38% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 89
10% more capital invested
Capital invested by funds: $2.12B [Q2] → $2.33B (+$212M) [Q3]
8% more funds holding
Funds holding: 284 [Q2] → 306 (+22) [Q3]
14.67% less ownership
Funds ownership: 111.54% [Q2] → 96.87% (-14.67%) [Q3]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
JMP Securities Constantine Davides 20% 1-year accuracy 5 / 25 met price target | 14%upside $150 | Market Outperform Initiated | 16 Dec 2024 |
RBC Capital Ben Hendrix 25% 1-year accuracy 18 / 71 met price target | 4%upside $136 | Outperform Reiterated | 14 Nov 2024 |
Stephens & Co. Scott Fidel 51% 1-year accuracy 22 / 43 met price target | 10%upside $145 | Overweight Maintained | 6 Nov 2024 |
Macquarie Tao Qiu 33% 1-year accuracy 5 / 15 met price target | 6%upside $139 | Outperform Maintained | 4 Nov 2024 |
Keybanc Matthew Gillmor 27% 1-year accuracy 3 / 11 met price target | 14%upside $150 | Overweight Initiated | 11 Oct 2024 |
Financial journalist opinion
Based on 4 articles about ADUS published over the past 30 days